OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during theCOVID ‐19 pandemic
Jose W. Ricardo, Shari R. Lipner
Dermatologic Therapy (2020) Vol. 33, Iss. 5
Open Access | Times Cited: 48
Jose W. Ricardo, Shari R. Lipner
Dermatologic Therapy (2020) Vol. 33, Iss. 5
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, et al.
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 4, pp. 425-442
Open Access | Times Cited: 84
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, et al.
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 4, pp. 425-442
Open Access | Times Cited: 84
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
Saman Sargazi, Rabia Arshad, Reza Ghamari, et al.
Cell Biology International (2022) Vol. 46, Iss. 9, pp. 1320-1344
Open Access | Times Cited: 42
Saman Sargazi, Rabia Arshad, Reza Ghamari, et al.
Cell Biology International (2022) Vol. 46, Iss. 9, pp. 1320-1344
Open Access | Times Cited: 42
SARS‐CoV‐2‐mediated immune system activation and potential application in immunotherapy
Yuan Tan, Faqin Tang
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 1167-1194
Open Access | Times Cited: 55
Yuan Tan, Faqin Tang
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 1167-1194
Open Access | Times Cited: 55
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease
Alfonso Motolese, Manuela Ceccarelli, Laura Macca, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 228-228
Open Access | Times Cited: 29
Alfonso Motolese, Manuela Ceccarelli, Laura Macca, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 228-228
Open Access | Times Cited: 29
Rubén Queiró, Susana Armesto, Carmen González Vela, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 37
Skin manifestations of COVID‐19 in children: Part 3
David Andina Martínez, Anna Belloni Fortina, Christine Bodemer, et al.
Clinical and Experimental Dermatology (2020) Vol. 46, Iss. 3, pp. 462-472
Open Access | Times Cited: 35
David Andina Martínez, Anna Belloni Fortina, Christine Bodemer, et al.
Clinical and Experimental Dermatology (2020) Vol. 46, Iss. 3, pp. 462-472
Open Access | Times Cited: 35
Immunosuppressive drugs for patients with psoriasis during the COVID ‐19 pandemic era. A review
Ali Sadeghinia, Maryam Daneshpazhooh
Dermatologic Therapy (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 25
Ali Sadeghinia, Maryam Daneshpazhooh
Dermatologic Therapy (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 25
Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
Dimitri Poddighe, Elena Kovzel
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6845-6853
Open Access | Times Cited: 23
Dimitri Poddighe, Elena Kovzel
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6845-6853
Open Access | Times Cited: 23
Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
Joanna Sieniawska, Aleksandra Lesiak, Karol Ciążyński, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1734-1734
Open Access | Times Cited: 14
Joanna Sieniawska, Aleksandra Lesiak, Karol Ciążyński, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1734-1734
Open Access | Times Cited: 14
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies
Federico Pirrò, Giacomo Caldarola, Andrea Chiricozzi, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 2, pp. 1079-1083
Closed Access | Times Cited: 23
Federico Pirrò, Giacomo Caldarola, Andrea Chiricozzi, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 2, pp. 1079-1083
Closed Access | Times Cited: 23
A case of severe psoriatic erythroderma with COVID-19
Fariba Ghalamkarpour, Mohammad Reza Pourani, Fahimeh Abdollahimajd, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 2, pp. 1111-1113
Closed Access | Times Cited: 19
Fariba Ghalamkarpour, Mohammad Reza Pourani, Fahimeh Abdollahimajd, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 2, pp. 1111-1113
Closed Access | Times Cited: 19
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID‐19
Maria Passante, Maddalena Napolitano, Stefano Dastoli, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 6
Open Access | Times Cited: 16
Maria Passante, Maddalena Napolitano, Stefano Dastoli, et al.
Dermatologic Therapy (2021) Vol. 34, Iss. 6
Open Access | Times Cited: 16
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19
Tatiana Mina Yendo, Maria Notomi Sato, Anna Cláudia Calvielli Castelo Branco, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 478-478
Open Access | Times Cited: 11
Tatiana Mina Yendo, Maria Notomi Sato, Anna Cláudia Calvielli Castelo Branco, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 478-478
Open Access | Times Cited: 11
The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients
Martyna Miodońska, Agnieszka Bogacz-Piaseczyńska, Magdalena Mróz, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 521-521
Open Access | Times Cited: 11
Martyna Miodońska, Agnieszka Bogacz-Piaseczyńska, Magdalena Mróz, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 521-521
Open Access | Times Cited: 11
Atopic dermatitis in the COVID-19 era: Results from a web-based survey
Noelia Andrés Hernández, Gloria Sanclemente, Liliana Tamayo, et al.
World Allergy Organization Journal (2021) Vol. 14, Iss. 8, pp. 100571-100571
Open Access | Times Cited: 11
Noelia Andrés Hernández, Gloria Sanclemente, Liliana Tamayo, et al.
World Allergy Organization Journal (2021) Vol. 14, Iss. 8, pp. 100571-100571
Open Access | Times Cited: 11
The Features of Shared Genes among Transcriptomes Probed in Atopic Dermatitis, Psoriasis, and Inflammatory Acne: S100A9 Selection as the Target Gene
Wei Wang, Sungbo Hwang, Daeui Park, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 5, pp. 356-374
Closed Access | Times Cited: 1
Wei Wang, Sungbo Hwang, Daeui Park, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 5, pp. 356-374
Closed Access | Times Cited: 1
How does COVID‐19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross‐sectional survey study
Mohamed H.M. El-Komy, Asmaa Abdelnaby, Mona El‐Kalioby
Journal of Cosmetic Dermatology (2021) Vol. 20, Iss. 6, pp. 1573-1579
Open Access | Times Cited: 10
Mohamed H.M. El-Komy, Asmaa Abdelnaby, Mona El‐Kalioby
Journal of Cosmetic Dermatology (2021) Vol. 20, Iss. 6, pp. 1573-1579
Open Access | Times Cited: 10
Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis
Meitong Liu, Huijuan Wang, Lu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Meitong Liu, Huijuan Wang, Lu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey
Nikolai Loft, Anne‐Sofie Halling, Lars Iversen, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 12
Open Access | Times Cited: 10
Nikolai Loft, Anne‐Sofie Halling, Lars Iversen, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 12
Open Access | Times Cited: 10
Dupilumab in atopic dermatitis, a protocol for SARS‐COV‐ 2‐infected patients
María Fernanda Ordóñez, I Villar del Campo, Mirian Casas
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 9
María Fernanda Ordóñez, I Villar del Campo, Mirian Casas
Dermatologic Therapy (2020) Vol. 33, Iss. 6
Open Access | Times Cited: 9
Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single‐centre pilot study
Tarun Narang, Raihan Ashraf, Akanksha Kaushik, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 12
Closed Access | Times Cited: 9
Tarun Narang, Raihan Ashraf, Akanksha Kaushik, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 12
Closed Access | Times Cited: 9
Comparative Study on the Clinical Efficacy and Safety of Acitretin and MTX in the Treatment of Pustular Psoriasis by TLR7/MyD88/CXCL16 Pathway
Jiajing Lu, Yu Wang, Ying Li, et al.
Applied Bionics and Biomechanics (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 6
Jiajing Lu, Yu Wang, Ying Li, et al.
Applied Bionics and Biomechanics (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 6
Impact of COVID-19 on patients with atopic dermatitis
Teresa Grieco, Camilla Chello, Alvise Sernicola, et al.
Clinics in Dermatology (2021) Vol. 39, Iss. 6, pp. 1083-1087
Open Access | Times Cited: 8
Teresa Grieco, Camilla Chello, Alvise Sernicola, et al.
Clinics in Dermatology (2021) Vol. 39, Iss. 6, pp. 1083-1087
Open Access | Times Cited: 8
